Protection of muscle from secondary effects of dystrophin deficiency such as inflammation, metabolic dysfunction and free radical injury while simultaneously driving utrophin expression and mitochondrial biogenesis may slow disease progression and prolong muscle function. The gene discussed is UTRN; the disease is hyperinsulinemic hypoglycemia, familial, 4.